ES527711A0 - Un procedimiento para la preparacion de derivados de -lactama - Google Patents

Un procedimiento para la preparacion de derivados de -lactama

Info

Publication number
ES527711A0
ES527711A0 ES527711A ES527711A ES527711A0 ES 527711 A0 ES527711 A0 ES 527711A0 ES 527711 A ES527711 A ES 527711A ES 527711 A ES527711 A ES 527711A ES 527711 A0 ES527711 A0 ES 527711A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
lactam derivatives
lactam
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES527711A
Other languages
English (en)
Other versions
ES8604511A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES527711A0 publication Critical patent/ES527711A0/es
Publication of ES8604511A1 publication Critical patent/ES8604511A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/261-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring
ES527711A 1982-03-31 1983-12-01 Un procedimiento para la preparacion de derivados de -lactama Expired ES8604511A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8209426 1982-03-31

Publications (2)

Publication Number Publication Date
ES527711A0 true ES527711A0 (es) 1986-02-01
ES8604511A1 ES8604511A1 (es) 1986-02-01

Family

ID=10529420

Family Applications (2)

Application Number Title Priority Date Filing Date
ES521192A Granted ES521192A0 (es) 1982-03-31 1983-03-30 Un procedimiento para la preparacion de derivados de b-lactama.
ES527711A Expired ES8604511A1 (es) 1982-03-31 1983-12-01 Un procedimiento para la preparacion de derivados de -lactama

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES521192A Granted ES521192A0 (es) 1982-03-31 1983-03-30 Un procedimiento para la preparacion de derivados de b-lactama.

Country Status (7)

Country Link
US (1) US4537886A (es)
EP (1) EP0090656A1 (es)
JP (1) JPS58183692A (es)
AU (1) AU1294383A (es)
ES (2) ES521192A0 (es)
NZ (1) NZ203734A (es)
ZA (1) ZA832226B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409986D0 (en) * 1984-04-17 1984-05-31 Beecham Group Plc Beta-lactam antibacterial agents
DE3508258A1 (de) * 1985-03-08 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
DE3509618A1 (de) * 1985-03-16 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactam-antibiotika, verfahren zur herstellung und ihre verwendung als arzneimittel
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
DE3803169A1 (de) * 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
US5128336A (en) * 1988-03-23 1992-07-07 Eli Lilly And Company 3-(substituted)-1-carba(dethia)-3-cephems
US20050245498A1 (en) * 2002-05-14 2005-11-03 Shoichet Brian K Sterically-awkward beta-lactamase inhibitors
US20080146535A1 (en) * 2003-04-30 2008-06-19 Tomasz Glinka Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors
EA201070504A1 (ru) * 2007-10-25 2010-12-30 Эйкеоджен, Инк. КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2017106064A1 (en) * 2015-12-15 2017-06-22 Merck Sharp & Dohme Corp. Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448966A1 (de) * 1973-10-19 1975-04-30 Yamanouchi Pharma Co Ltd Penicillinderivate
JPS5195090A (en) * 1975-02-14 1976-08-20 66 * dd22 * 33 hidorokishipiridajin 44 karubokishiamido * 22 * paraahidorokishifueniru * asetoamido * penishiransanno seiho
DE2720579A1 (de) * 1977-05-07 1978-11-09 Bayer Ag Beta-lactam-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2810083A1 (de) * 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
JPS5616489A (en) * 1979-07-20 1981-02-17 Ajinomoto Co Inc Imidazolecarboxylic acid derivative

Also Published As

Publication number Publication date
EP0090656A1 (en) 1983-10-05
NZ203734A (en) 1986-03-14
ES8405411A1 (es) 1984-06-01
ES8604511A1 (es) 1986-02-01
JPS58183692A (ja) 1983-10-26
ES521192A0 (es) 1984-06-01
AU1294383A (en) 1983-10-06
US4537886A (en) 1985-08-27
ZA832226B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
ES521121A0 (es) Un procedimiento para la preparacion de derivados de benzotia-zolsulfonamida.
ES530714A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES524446A0 (es) Un procedimiento para la preparacion de nuevos derivados.
ES522678A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES524447A0 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES528003A0 (es) Un procedimiento para preparar derivados de cefem
ES524610A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES537350A0 (es) Un procedimiento para la preparacion de compuestos de -lactama
ES527711A0 (es) Un procedimiento para la preparacion de derivados de -lactama
ES522389A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.
ES526528A0 (es) Un procedimiento para la preparacion de derivados de difenilalquilenicos.
ES540341A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ES527804A0 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES527806A0 (es) Un procedimiento para la preparacion de derivados de -lactama
ES527738A0 (es) Un procedimiento para preparar derivados de piridona
ES520338A0 (es) Un procedimiento para la preparacion de derivados pentaciclicos.
ES524452A0 (es) Un procedimiento para la preparacion de derivados de pirazolo-quinolinas.
ES522262A0 (es) Un procedimiento para la preparacion de nuevos derivados de dihidronaftiridina.
ES527789A0 (es) Un procedimiento para preparar derivados de cicloalquenilo